Trinity Biotech (TRIB) EPS (Basic) Growth (5y) (2014 - 2024)
Trinity Biotech (TRIB) EPS (Basic) Growth (5y) (2014 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Trinity Biotech | 93,750.00 | -5.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1,454.33% |
| Sep 30, 2024 | -80.88% |
| Jun 30, 2024 | 35.58% |
| Mar 31, 2024 | -11.42% |
| Dec 31, 2023 | -1,356.13% |
| Sep 30, 2023 | -17.13% |
| Jun 30, 2023 | -17.82% |
| Mar 31, 2023 | -63.96% |
| Dec 31, 2022 | -1,995.48% |
| Sep 30, 2022 | -41.88% |
| Jun 30, 2022 | -31.99% |
| Mar 31, 2022 | -66.58% |
| Dec 31, 2021 | -1,200.65% |
| Sep 30, 2021 | 37.03% |
| Jun 30, 2021 | -19.26% |
| Mar 31, 2021 | 27.11% |
| Dec 31, 2020 | -42.76% |
| Sep 30, 2020 | -91.17% |
| Jun 30, 2020 | -14.87% |
| Mar 31, 2020 | -14.87% |